With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

For any parent, the arrival of a new baby is joyful. But for a Hanover, Minnesota, family, a prenatal checkup turned into ...

Though late to the party compared to other industry mammoths, Abbott joins a pulsed field ablation market poised for ...

Pentagon says Guam could be 1st target of Chinese missiles during Taiwan invasion ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Abbott (NYSE: ABT) will announce its first-quarter 2025 financial results on Wednesday, April 16, before the market opens.

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and ...